Literature DB >> 8624878

Bidirectional superior cavopulmonary anastomosis: how young is too young?

Z Slavik1, R K Lamb, S A Webber, A M Devlin, B R Keeton, J L Monro, A P Salmon.   

Abstract

OBJECTIVE: To define the lowest age at which the bidirectional superior cavopulmonary anastomosis can safely be used in infants with complex congenital heart defects.
DESIGN: A retrospective analysis of clinical, echocardiographic, haemodynamic, and angiographic data in four consecutive patients undergoing bidirectional superior cavopulmonary anastomosis below the age of 2 months. PATIENTS: Between November 1990 and September 1993, four infants less than 8 weeks of age (3, 4, 6, and 7 weeks) underwent bidirectional superior cavopulmonary anastomosis as a primary palliation for complex heart disease. The indication for early surgical intervention was progression of cyanosis (n = 3) and high pulmonary blood flow causing heart failure (n = 1). In two infants with tricuspid atresia, surgery was performed through a right thoracotomy without the use of cardiopulmonary bypass. In one infant with double inlet left ventricle and discordant ventriculoarterial connection, cavopulmonary anastomosis was combined with an arterial switch procedure. The final infant had double inlet left ventricle with pulmonary atresia; the central pulmonary arteries were virtually discontinuous and each branch was supplied by a separate arterial duct. The central pulmonary arteries were reconstructed using the subaortic innominate vein. Temporary prostacyclin infusion was used in three patients in the immediate postoperative period.
RESULTS: Early postoperative extubation (5, 7, and 48 h) was successful in three patients. The youngest child required ligation of the ductus arteriosus four days later because of severe upper body oedema. The postoperative course was complicated by prolonged effusions in two patients. All were alive and well 14-48 months postoperatively, with satisfactory systemic saturations (80-87%) and haemodynamic indices.
CONCLUSIONS: This limited experience challenges the widely held belief that the bidirectional superior cavopulmonary anastomosis cannot be used as a primary palliation for complex heart disease in early infancy. A wider experience is required to determine the safety and indications for this approach.

Entities:  

Mesh:

Year:  1996        PMID: 8624878      PMCID: PMC484228          DOI: 10.1136/hrt.75.1.78

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  12 in total

1.  Superior vena cava-pulmonary artery shunt. By William W. L. Glenn, 1958.

Authors:  W W Glenn
Journal:  Ann Thorac Surg       Date:  1989-01       Impact factor: 4.330

2.  Subaortic stenosis, the univentricular heart, and banding of the pulmonary artery: an analysis of the courses of 43 patients with univentricular heart palliated by pulmonary artery banding.

Authors:  R M Freedom; L N Benson; J F Smallhorn; W G Williams; G A Trusler; R D Rowe
Journal:  Circulation       Date:  1986-04       Impact factor: 29.690

3.  Is banding of the pulmonary trunk obsolete for infants with tricuspid atresia and double inlet ventricle with a discordant ventriculoarterial connection? Role of aortic arch obstruction and subaortic stenosis.

Authors:  R C Franklin; I D Sullivan; R H Anderson; E A Shinebourne; J E Deanfield
Journal:  J Am Coll Cardiol       Date:  1990-11       Impact factor: 24.094

4.  The bidirectional cavopulmonary shunt.

Authors:  J J Lamberti; R L Spicer; J D Waldman; T M Grehl; D Thomson; L George; S E Kirkpatrick; J W Mathewson
Journal:  J Thorac Cardiovasc Surg       Date:  1990-07       Impact factor: 5.209

5.  Thirty-year follow-up of superior vena cava-pulmonary artery (Glenn) shunts.

Authors:  G S Kopf; H Laks; H C Stansel; W E Hellenbrand; C S Kleinman; N S Talner
Journal:  J Thorac Cardiovasc Surg       Date:  1990-11       Impact factor: 5.209

6.  Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass.

Authors:  D L Wessel; I Adatia; T M Giglia; J E Thompson; T J Kulik
Journal:  Circulation       Date:  1993-11       Impact factor: 29.690

7.  Bidirectional cavopulmonary anastomosis in patients under two years of age.

Authors:  S B Albanese; A Carotti; R M Di Donato; E Mazzera; C J Troconis; S Giannico; S Picardo; C Marcelletti
Journal:  J Thorac Cardiovasc Surg       Date:  1992-10       Impact factor: 5.209

8.  Relation between preoperative left ventricular muscle mass and outcome of the Fontan procedure in patients with tricuspid atresia.

Authors:  M Seliem; A J Muster; M H Paul; D W Benson
Journal:  J Am Coll Cardiol       Date:  1989-09       Impact factor: 24.094

9.  Cavopulmonary anastomosis as long-term palliation for patients with tricuspid atresia.

Authors:  A P Salmon; B Sethia; E D Silove; D Goh; I Mitchell; H Alton; J V De Giovanni; J G Wright; L D Abrams
Journal:  Eur J Cardiothorac Surg       Date:  1989       Impact factor: 4.191

10.  The Fontan operation. Ventricular hypertrophy, age, and date of operation as risk factors.

Authors:  J K Kirklin; E H Blackstone; J W Kirklin; A D Pacifico; L M Bargeron
Journal:  J Thorac Cardiovasc Surg       Date:  1986-12       Impact factor: 5.209

View more
  11 in total

1.  Around PediHeart: early bidirectional cavopulmonary anastomosis.

Authors:  F McCaffrey
Journal:  Pediatr Cardiol       Date:  2001 Sep-Oct       Impact factor: 1.655

2.  Bidirectional superior cavopulmonary anastomosis: how young is too young?

Authors:  S A Qureshi; E Rosenthal; M Tynan
Journal:  Heart       Date:  1997-07       Impact factor: 5.994

3.  Superior cavopulmonary anastomosis timing and outcomes in infants with single ventricle.

Authors:  James F Cnota; Kerstin R Allen; Steven Colan; Wesley Covitz; Eric M Graham; David A Hehir; Jami C Levine; Renee Margossian; Brian W McCrindle; L LuAnn Minich; Shobha Natarajan; Marc E Richmond; Daphne T Hsu
Journal:  J Thorac Cardiovasc Surg       Date:  2012-08-28       Impact factor: 5.209

4.  Risk factors for failed staged palliation after bidirectional Glenn in infants who have undergone stage one palliation.

Authors:  Kevin G Friedman; Joshua W Salvin; David Wypij; Yared Gurmu; Emile A Bacha; David W Brown; Peter C Laussen; Mark A Scheurer
Journal:  Eur J Cardiothorac Surg       Date:  2011-03-05       Impact factor: 4.191

5.  Center Variability in Timing of Stage 2 Palliation and Association with Interstage Mortality: A Report from the National Pediatric Cardiology Quality Improvement Collaborative.

Authors:  Garick D Hill; Nancy A Rudd; Nancy S Ghanayem; David A Hehir; Peter J Bartz
Journal:  Pediatr Cardiol       Date:  2016-08-24       Impact factor: 1.655

6.  Changes in pulmonary artery size before and after total cavopulmonary connection.

Authors:  G Buheitel; M Hofbeck; U Tenbrink; G Leipold; J von der Emde; H Singer
Journal:  Heart       Date:  1997-11       Impact factor: 5.994

7.  The Optimal Timing of Stage 2 Palliation for Hypoplastic Left Heart Syndrome: An Analysis of the Pediatric Heart Network Single Ventricle Reconstruction Trial Public Data Set.

Authors:  James M Meza; Edward J Hickey; Eugene H Blackstone; Robert D B Jaquiss; Brett R Anderson; William G Williams; Sally Cai; Glen S Van Arsdell; Tara Karamlou; Brian W McCrindle
Journal:  Circulation       Date:  2017-07-07       Impact factor: 29.690

8.  Reconstruction of nonconfluent pulmonary artery using the retroaortic innominate vein for a single ventricle.

Authors:  Masato Nakayama; Toshiaki Itou; Tomonobu Abe; Tomo Yoshizumi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-05-06

9.  Increased systemic cardiac output improves arterial oxygen saturation in bidirectional cavopulmonary shunt.

Authors:  Norihiko Oka; Kagami Miyaji; Tadashi Kitamura; Keiichi Itatani; Takeshi Yoshii; Nobuyuki Inoue; Takuma Fukunishi; Ko Shibata; Shinzo Torii
Journal:  Heart Vessels       Date:  2013-11-10       Impact factor: 2.037

Review 10.  Decision-Making for Surgery in the Management of Patients with Univentricular Heart.

Authors:  Ryan Robert Davies; Christian Pizarro
Journal:  Front Pediatr       Date:  2015-07-27       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.